{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:21:07Z","timestamp":1760300467998,"version":"3.44.0"},"reference-count":52,"publisher":"The Pediatric Pharmacy Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p>Management of neonatal patent ductus arteriosus (PDA) often is resource-intensive and costly. Therefore, it is in hospitals' best interests to ensure the most cost-efficient use of associated resources. Clinical status, comorbidities, and response to prior therapy are considered in selecting the most appropriate intervention for PDA management. Currently, supportive measures (e.g., fluid restriction), surgical ligation, and pharmacologically based medical therapy are the primary treatment modalities for correcting PDA. Medical therapy, which comprises a small percentage (2.0%\u20135.0%)1 of overall PDA treatment expenses in the United States, consists of either of the 2 intravenous (IV) cyclooxygenase (COX) inhibitors: IV indomethacin and the newly available IV ibuprofen lysine. Although IV COX inhibitors represent a small portion of medical expenses, their benefits appear to be considerable. Pharmacoeconomic studies have evaluated indomethacin's beneficial impact on cost-effectiveness per quality-adjusted life year in PDA prophylaxis; however, no analysis to date prospectively assesses the effect of COX inhibitors on resource use or expenses in treating PDA. Such analysis is desirable and should consider efficacy and safety outcomes, impact on health care resource use and length of stay (LOS), and any differential effects of the agents' safety profiles; notably, IV indomethacin adversely affects renal and mesenteric blood flow and increases serum creatinine and oliguria significantly more than IV ibuprofen. These observations lay the foundation to conduct studies assessing the influence of these differences on resource use, LOS and expenses associated with PDA management.<\/jats:p>","DOI":"10.5863\/1551-6776-12.3.183","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:13:37Z","timestamp":1603829617000},"page":"183-193","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus"],"prefix":"10.5863","volume":"12","author":[{"given":"Charles J","family":"Turck","sequence":"first","affiliation":[{"name":"University of Massachusetts Memorial Medical Center, Worcester, Massachusetts"},{"name":"Akita Biomedical Consulting, San Clemente, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallace","family":"Marsh","sequence":"additional","affiliation":[{"name":"Shenendoah University School of Pharmacy, Winchester, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"York","sequence":"additional","affiliation":[{"name":"Akita Biomedical Consulting, San Clemente, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Miller","sequence":"additional","affiliation":[{"name":"Navigant Consulting, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snehal","family":"Patel","sequence":"additional","affiliation":[{"name":"Covance Market Access Services Inc., Gaithersburg, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"year":"2006","series-title":"An evaluation of the current and future reimbursement environment for Indocin I.V. in the management of preterm newborns with patent ductus arteriosus","key":"i1551-6776-12-3-183-b1","unstructured":"Miller\n              H\n            , MyersC, PatelS.\n          An evaluation of the current and future reimbursement environment for Indocin I.V. in the management of preterm newborns with patent ductus arteriosus. Baltimore, MD: Navigant Consulting;2006."},{"key":"i1551-6776-12-3-183-b2","series-title":"Neonatology: management, procedures, on-call problems, diseases, and drugs","first-page":"335","article-title":"Cardiac abnormalities","year":"1999","unstructured":"Cardiac abnormalities. In: GomellaTL, CunninghamMD, EyalFG, et al., eds. Neonatology: management, procedures, on-call problems, diseases, and drugs. 4th ed. Stamford, CT: Appleton & Lange; 1999:335\u2013352."},{"key":"i1551-6776-12-3-183-b3","unstructured":"Agency for Healthcare Quality and Research. Healthcare Cost and Utilization Project. Introduction to the HCUP KIDS Inpatient Database. Available at: http:\/\/www.hcup-us.ahrq.gov\/db\/nation\/kid\/Introduction_to_KID_2003.pdf. Accessed February 7, 2007.","article-title":"Healthcare Cost and Utilization Project. Introduction to the HCUP KIDS Inpatient Database"},{"key":"i1551-6776-12-3-183-b4","series-title":"Pediatric Cardiology for Practitioners","first-page":"93","article-title":"Fetal and perinatal circulation","year":"1996","unstructured":"Park\n              MY.\n            \n          \n          Fetal and perinatal circulation. In: CravanL, ed. Pediatric Cardiology for Practitioners. St. Louis, MO: Mosby-Year Book; 1996:93\u201398."},{"key":"i1551-6776-12-3-183-b5","series-title":"Semin Perinatol","first-page":"281","article-title":"The NICHD Neonatal Research Network: changes in practice and outcomes during the first 15 years","volume":"27","year":"2003","unstructured":"Fanaroff\n              AA\n            , HackM, WalshMC.\n          The NICHD Neonatal Research Network: changes in practice and outcomes during the first 15 years. Semin Perinatol2003;27:281\u2013287."},{"key":"i1551-6776-12-3-183-b6","series-title":"Pediatric Cardiology for Practitioners","first-page":"374","article-title":"Manifestations of cardiac problems in newborns","year":"2002","unstructured":"Manifestations of cardiac problems in newborns. In: ParkMK, TroxlerRG, eds. Pediatric Cardiology for Practitioners. 4th ed. St. Louis, MO: Mosby; 2002:374\u2013400."},{"key":"i1551-6776-12-3-183-b7","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"F179","article-title":"Treatment of patent ductus arteriosus with ibuprofen","volume":"76","year":"1997","unstructured":"Van Overmeire\n              B\n            , FollensI, HartmannS, et al. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed1997;76:F179\u2013F184."},{"key":"i1551-6776-12-3-183-b8","series-title":"Eur J Pediatr","first-page":"202","article-title":"Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial","volume":"161","year":"2002","unstructured":"Lago\n              P\n            , BettiolT, SalvadoriS, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr2002;161:202\u2013207."},{"key":"i1551-6776-12-3-183-b9","series-title":"Pediatric Cardiology for Practitioners","first-page":"131","article-title":"Left-to-right shunt lesions","year":"2002","unstructured":"Left-to-right shunt lesions. In: ParkMK, TroxlerRG, eds. Pediatric Cardiology for Practitioners. 4th ed. St. Louis, MO: Mosby; 2002:131\u2013156."},{"key":"i1551-6776-12-3-183-b10","series-title":"J Pediatr","first-page":"229","article-title":"Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: Results from the Trial of Indomethacin Prophylaxis in Preterms","volume":"150","year":"2007","unstructured":"Kabra\n              NS\n            , SchmidtB, RobertsRS, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: Results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr2007;150:229\u2013234."},{"year":"July 2006","series-title":"Indocin\u00ae IV (indomethacin) package insert","key":"i1551-6776-12-3-183-b11","unstructured":"Ovation Pharmaceuticals. Indocin\u00ae IV (indomethacin) package insert. Deerfield, IL; July 2006."},{"year":"April 2006","series-title":"NeoProfen\u00ae (ibuprofen lysine) package insert","key":"i1551-6776-12-3-183-b12","unstructured":"Ovation Pharmaceuticals. NeoProfen\u00ae (ibuprofen lysine) package insert. Deerfield, IL; April 2006."},{"key":"i1551-6776-12-3-183-b13","series-title":"2007 Red Book","first-page":"484","year":"2007","unstructured":"2007 Red Book. Montvale, NJ: Thompson PDR; 2007:484, 575."},{"key":"i1551-6776-12-3-183-b14","unstructured":"United States Pharmacopeia. Pharmaceutical Compounding\u2014Sterile Preparations. Available at: http:\/\/www.usp.org\/pdf\/EN\/USPNF\/PF797redline.pdf. Accessed April 3, 2007.","article-title":"Pharmaceutical Compounding\u2014Sterile Preparations"},{"key":"i1551-6776-12-3-183-b15","unstructured":"Joint Commission on the Accreditation of Healthcare Organizations. Critical Access Hospital 2006 Medication Management. Available from: http:\/\/www.jointcommission.org\/NR\/rdonlyres\/E6504BF2-E51E-4141\u20138777-E61380C10B91\/0\/06_cah_mm.pdf. Accessed April 3, 2007.","article-title":"Joint Commission on the Accreditation of Healthcare Organizations. Critical Access Hospital 2006 Medication Management"},{"key":"i1551-6776-12-3-183-b16","series-title":"Consult Pharm","first-page":"690","article-title":"Cost analysis of solid oral medication distribution and administration: applications for chronic nitrate therapy","volume":"12","year":"1997","unstructured":"Gonzalez\n              ER\n            , ChaponisRJ, ElswickRK, et al. Cost analysis of solid oral medication distribution and administration: applications for chronic nitrate therapy. Consult Pharm1997;12:690\u2013702."},{"key":"i1551-6776-12-3-183-b17","series-title":"J Clin Pharm Ther","first-page":"73","article-title":"Use of pharmacoeconomics in prescribing research\u2014 Part 1: costs\u2014moving beyond the acquisition prices of drugs","volume":"28","year":"2003","unstructured":"Robertson\n              J\n            , LandD, HillS.\n          Use of pharmacoeconomics in prescribing research\u2014 Part 1: costs\u2014moving beyond the acquisition prices of drugs. J Clin Pharm Ther2003;28:73\u201379."},{"key":"i1551-6776-12-3-183-b18","series-title":"Ann Pharmacother","first-page":"218","article-title":"Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants","volume":"36","year":"2002","unstructured":"Moya\n              MP\n            , GoldbergRN.\n          Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants. Ann Pharmacother2002;36:218\u2013224."},{"key":"i1551-6776-12-3-183-b19","series-title":"Early Hum Dev","first-page":"97","article-title":"Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants","volume":"82","year":"2006","unstructured":"Zupancic\n              JAF\n            , RichardsonDK, O'BrienBJ, et al. Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants. Early Hum Dev2006;82:97\u2013103."},{"key":"i1551-6776-12-3-183-b20","series-title":"J Perinatol","first-page":"158","article-title":"Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?","volume":"27","year":"2007","unstructured":"Cordero\n              L\n            , NankervisCA, DeloozeD, et al. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?J Perinatol2007;27:158\u2013163."},{"key":"i1551-6776-12-3-183-b21","series-title":"\u00c7ocuk Sagligi ve Hastaliklari Dergisi","first-page":"56","article-title":"Premat\u00fcre bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve g\u00fcvenilirligi","volume":"44","year":"2001","unstructured":"Akis\u00fc\n              M\n            , \u00d6zy\u00fcrekAR, DorakC, et al. Premat\u00fcre bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve g\u00fcvenilirligi. \u00c7ocuk Sagligi ve Hastaliklari Dergisi2001;44:56\u201360."},{"key":"i1551-6776-12-3-183-b22","series-title":"Semin Perinatol","first-page":"114","article-title":"Systematic review: intravenous ibuprofen in preterm newborns","volume":"30","year":"2006","unstructured":"Aranda\n              JV\n            , ThomasR.\n          Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol2006;30:114\u2013120."},{"key":"i1551-6776-12-3-183-b23","series-title":"N Engl J Med","first-page":"728","article-title":"Ibuprofen and patent ductus arteriosus","volume":"343","year":"2000","unstructured":"Clyman\n              RI.\n            \n          \n          Ibuprofen and patent ductus arteriosus. N Engl J Med2000;343:728\u2013729."},{"key":"i1551-6776-12-3-183-b24","series-title":"Neonat Netw","first-page":"27","article-title":"Alternative treatment for patent ductus arteriosus","volume":"22","year":"2003","unstructured":"Flores\n              M.\n            \n          \n          Alternative treatment for patent ductus arteriosus. Neonat Netw2003;22:27\u201331."},{"key":"i1551-6776-12-3-183-b25","series-title":"eNeonat Rev","first-page":"4","article-title":"Intravenous (IV) ibuprofen treatment compared to IV indomethacin for PDA","volume":"4","year":"2007","unstructured":"Meekins\n              MD.\n            \n          \n          Intravenous (IV) ibuprofen treatment compared to IV indomethacin for PDA. eNeonat Rev2007;4:4\u20136."},{"key":"i1551-6776-12-3-183-b26","series-title":"J Pediatr","first-page":"549","article-title":"Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus","volume":"131","year":"1997","unstructured":"Mosca\n              F\n            , BrayM, LattanzioM, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr1997;131:549\u2013554."},{"issue":"Issue 4","key":"i1551-6776-12-3-183-b27","series-title":"The Cochrane Database of Systematic Reviews","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants","year":"2005","unstructured":"Ohlsson\n              A\n            , WaliaR, ShahS.\n          Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants. The Cochrane Database of Systematic Reviews2005, Issue 4. Art. No.: CD003481.pub2. DOI:10.1002\/14651858.CD003481.pub2."},{"key":"i1551-6776-12-3-183-b28","series-title":"Lancet","first-page":"255","article-title":"Ibuprofen treatment of patent ductus arteriosus","volume":"346","year":"1995","unstructured":"Patel\n              J\n            , MarksKA, RobertsI, et al. Ibuprofen treatment of patent ductus arteriosus. Lancet1995;346:255."},{"key":"i1551-6776-12-3-183-b29","series-title":"J Pediatr","first-page":"733","article-title":"Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus","volume":"135","year":"1999","unstructured":"Pezzati\n              M\n            , VangiV, BiagiottiR, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr1999;135:733\u2013738."},{"key":"i1551-6776-12-3-183-b30","series-title":"Pediatr Int","first-page":"665","article-title":"Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants","volume":"45","year":"2003","unstructured":"Su\n              P-H\n            , ChenJ-Y, SuC-M, et al. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int2003;45:665\u2013670."},{"issue":"Suppl 4","key":"i1551-6776-12-3-183-b31","series-title":"J Med Assoc Thai","first-page":"S1252","article-title":"Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital","volume":"85","year":"2002","unstructured":"Supapannachart\n              S\n            , LimrungsikulA, KhowsathitP.\n          Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai2002;85(Suppl 4):S1252\u20131258."},{"key":"i1551-6776-12-3-183-b32","series-title":"Arch Dis Child","first-page":"1134","article-title":"Is indomethacin or ibuprofen better for medical closure of the patent ductus arteriosus?","volume":"88","year":"2003","unstructured":"Swartz\n              EN.\n            \n          \n          Is indomethacin or ibuprofen better for medical closure of the patent ductus arteriosus?\n          Arch Dis Child\n          2003;88:1134\u20131135."},{"key":"i1551-6776-12-3-183-b33","series-title":"N Engl J Med","first-page":"674","article-title":"A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus","volume":"343","year":"2000","unstructured":"Van Overmeire\n              B\n            , SmetsK, LecoutereD, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med2000;343:674\u2013681."},{"key":"i1551-6776-12-3-183-b34","series-title":"Lancet","first-page":"1945","article-title":"Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"364","year":"2004","unstructured":"Van Overmeire\n              B\n            , AllegaertK, CasaerA, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet2004;364:1945\u20131949."},{"key":"i1551-6776-12-3-183-b35","series-title":"JAMA","first-page":"539","article-title":"Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants","volume":"275","year":"1996","unstructured":"Varvarigou\n              A\n            , BardinCL, BeharryK, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA1996;275:539\u2013544."},{"key":"i1551-6776-12-3-183-b36","series-title":"Bar Code Label Requirement for Human Drug Products and Blood","first-page":"12499","year":"2003","unstructured":"Bar Code Label Requirement for Human Drug Products and Blood. Rockville, MD: United States Department of Health and Human Services, Food and Drug Administration: Federal Register Docket Number 02N-0204;2003:12499\u201312534."},{"key":"i1551-6776-12-3-183-b37","series-title":"JAMA","first-page":"307","article-title":"The costs of adverse drug events in hospitalized patients","volume":"277","year":"1997","unstructured":"Bates\n              DW\n            , SpellN, CullenDJ, et al. The costs of adverse drug events in hospitalized patients. JAMA1997;277:307\u2013311."},{"issue":"Suppl 3","key":"i1551-6776-12-3-183-b38","series-title":"J Med Assoc Thai","first-page":"S563","article-title":"A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants","volume":"86","year":"2003","unstructured":"Chotigeat\n              U\n            , JirapapaK, LayangkoolT.\n          A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai2003;86(Suppl 3):S563\u2013569."},{"key":"i1551-6776-12-3-183-b39","series-title":"Drug Saf","first-page":"537","article-title":"Comparative tolerability of pharmacological treatments for patent ductus arteriosus","volume":"24","year":"2001","unstructured":"Hammerman\n              C\n            , KaplanM.\n          Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Saf2001;24:537\u2013551."},{"key":"i1551-6776-12-3-183-b40","series-title":"Biol Neonate","first-page":"242","article-title":"Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets","volume":"76","year":"1999","unstructured":"Speziale\n              MV\n            , AllenRG, HendersonCR, et al. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate1999;76:242\u2013252."},{"key":"i1551-6776-12-3-183-b41","series-title":"Eur J Pediatr","first-page":"135","article-title":"A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus","volume":"164","year":"2005","unstructured":"Thomas\n              RL\n            , ParkerGC, VanOvermeire B, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr2005;164:135\u2013140."},{"key":"i1551-6776-12-3-183-b42","series-title":"J Pediatr Surg","first-page":"738","article-title":"Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia","volume":"18","year":"1983","unstructured":"Grosfeld\n              JL\n            , KammanK, GrossK, et al.Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia. J Pediatr Surg1983;18:738\u2013742."},{"key":"i1551-6776-12-3-183-b43","series-title":"J Pharmacol Exp Ther","first-page":"679","article-title":"Differential effects of ibuprofen and indomethacin in the regional circulation of the dog","volume":"219","year":"1981","unstructured":"Feigen\n              LP\n            , KingLW, RayJ, et al. Differential effects of ibuprofen and indomethacin in the regional circulation of the dog. J Pharmacol Exp Ther1981;219:679\u2013684."},{"key":"i1551-6776-12-3-183-b44","series-title":"J Appl Physiol","first-page":"1672","article-title":"Indomethacin compromises hemodynamics during positive-pressure ventilation, independently of prostanoids","volume":"74","year":"1993","unstructured":"Malcolm\n              DD\n            , SegarJL, RobillardJE, et al. Indomethacin compromises hemodynamics during positive-pressure ventilation, independently of prostanoids. J Appl Physiol1993;74:1672\u20131678."},{"key":"i1551-6776-12-3-183-b45","series-title":"Ann Surg","first-page":"350","article-title":"Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin","volume":"224","year":"1996","unstructured":"Grosfeld\n              JL\n            , ChaetM, MolinariF, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg1996;224:350\u2013357."},{"key":"i1551-6776-12-3-183-b46","series-title":"Pediatr Res","first-page":"603","article-title":"Effect of indomethacin on cerebral oxidized cytochrome oxidase in preterm infants","volume":"33","year":"1993","unstructured":"McCormick\n              DC\n            , EdwardsAD, BrownGC, et al. Effect of indomethacin on cerebral oxidized cytochrome oxidase in preterm infants. Pediatr Res1993;33:603\u2013608."},{"key":"i1551-6776-12-3-183-b47","series-title":"Acta Paediatr","first-page":"82","article-title":"Effect of the cyclo-oxygenase blocker ibuprofen on cerebral blood volume and cerebral blood flow during normocarbia and hypercarbia in newborn piglets","volume":"88","year":"1999","unstructured":"Pellicer\n              A\n            , AparicioM, Caba\u00f1asF, et al. Effect of the cyclo-oxygenase blocker ibuprofen on cerebral blood volume and cerebral blood flow during normocarbia and hypercarbia in newborn piglets. Acta Paediatr1999;88:82\u201388."},{"key":"i1551-6776-12-3-183-b48","series-title":"Pediatr Res","first-page":"36","article-title":"Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus","volume":"47","year":"2000","unstructured":"Patel\n              J\n            , RobertsI, AzzopardiD, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res2000;47:36\u201342."},{"key":"i1551-6776-12-3-183-b49","series-title":"Pediatrics","first-page":"543","article-title":"Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial","volume":"93","year":"1994","unstructured":"Ment\n              LR\n            , OhW, EhrenkranzRA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics1994;93:543\u2013550."},{"key":"i1551-6776-12-3-183-b50","series-title":"J Pediatr","first-page":"948","article-title":"Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates","volume":"112","year":"1988","unstructured":"Ment\n              LR\n            , DuncanCC, EhrenkranzRA, et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr1988;112:948\u2013955."},{"key":"i1551-6776-12-3-183-b51","series-title":"Pediatrics","first-page":"485","article-title":"Outcome of children in the indomethacin intraventricular hemorrhage prevention trial","volume":"105","year":"2000","unstructured":"Ment\n              LR\n            , VohrB, AllanW, et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics2000;105:485\u2013491."},{"key":"i1551-6776-12-3-183-b52","series-title":"J Pediatr","first-page":"46","article-title":"Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice","volume":"150","year":"2007","unstructured":"Clyman\n              RI\n            , SahaS, JobeA, et al. Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice. J Pediatr2007;150:46\u201350."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/12\/3\/article-p183.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/12\/3\/183\/1783070\/1551-6776-12_3_183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/12\/3\/article-p183.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/12\/3\/article-p183.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:49:18Z","timestamp":1747356558000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/12\/3\/article-p183.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":52,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-12.3.183","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}